Literature DB >> 14669943

Monoclonal antibodies to thyroid specific autoantigens.

Takashi Akamizu1.   

Abstract

Monoclonal antibody (MAbs) is a powerful and essential tool to perform studies concerning antigens and antibodies at molecular level. MAbs to major thyroid specific autoantigens, thyroglobulin (Tg), thyroid peroxidase (TPO) and TSH receptor (TSHR), have been prepared and applied for a variety of investigations including the structure of antigens and antibodies, the expression of antigens, the epitopes of antibodies, the functional regions of antigens, mutated antigens in congenital diseases, and clinical applications to diagnosis of various thyroid diseases. Recently, sodium iodide symporter (NIS) was identified and became a potential thyroid autoantigen related to autoimmune thyroid disease, although few MAbs to NIS have been prepared. In this manuscript, I primarily focus on studies concerning MAbs to three major thyroid specific autoantigens, Tg, TPO and TSHR, and summarize studies using the mAbs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14669943     DOI: 10.1080/08916930310001603055

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  4 in total

Review 1.  Cell therapy for autoimmune diseases: does it have a future?

Authors:  A Radbruch; A Thiel
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

2.  B cells from patients with Graves' disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis.

Authors:  Raymond S Douglas; Vibharavi Naik; Catherine J Hwang; Nikoo F Afifiyan; Andrew G Gianoukakis; Daniel Sand; Shweta Kamat; Terry J Smith
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

3.  Divergent frequencies of IGF-I receptor-expressing blood lymphocytes in monozygotic twin pairs discordant for Graves' disease: evidence for a phenotypic signature ascribable to nongenetic factors.

Authors:  Raymond S Douglas; Thomas H Brix; Catherine J Hwang; Laszlo Hegedüs; Terry J Smith
Journal:  J Clin Endocrinol Metab       Date:  2009-02-24       Impact factor: 5.958

4.  The effects of royal jelly on autoimmunity in Graves' disease.

Authors:  Cihangir Erem; Orhan Deger; Ercüment Ovali; Yasam Barlak
Journal:  Endocrine       Date:  2006-10       Impact factor: 3.925

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.